• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新生儿体外膜肺氧合治疗非存活者的临床病理研究

A clinical-pathological study of nonsurvivors of newborn ECMO.

作者信息

Weber T R, Westfall S H, Sotelo C, Vogler C A, Tracy T

机构信息

Department of Surgery, Cardinal Glennon Children's Hospital, St Louis, MO 63104.

出版信息

J Pediatr Surg. 1993 Feb;28(2):135-7. doi: 10.1016/s0022-3468(05)80258-1.

DOI:10.1016/s0022-3468(05)80258-1
PMID:8437064
Abstract

Extracorporeal membrane oxygenation (ECMO) is an important means of supporting newborns with respiratory failure. While short- and long-term follow-up of ECMO survivors has been thoroughly addressed, there is no systematic study of nonsurvivors. Nineteen nonsurvivors of newborn ECMO with autopsy results are divided into two groups: group 1: 12 patients who had intracranial lesions as the primary cause of death (hemorrhage 8, encephalomalacia 2, infarct 2); and group 2: 7 patients with nonintracranial primary causes of death. Patients in group 1 were significantly more acidotic, hypotensive, and smaller in age and birth weight pre-ECMO. Among group 2 patients, two with diaphragmatic hernia died of primary pulmonary disease (diffuse alveolar damage, pulmonary hypoplasia and necrosis, bronchopneumonia). One of 2 patients with persistent fetal circulation (PFC) was treated with massive doses of tolazoline and suffered fatal gastrointestinal hemorrhage and ischemic necrosis of heart, spleen, testes, and adrenals. The other PFC patient had severe pulmonary interstitial fibrosis. Two patients with meconium aspiration and a patient with streptococcal sepsis had diffuse pulmonary damage and multiple organ failure (renal medullary necrosis, and infarcts of adrenal, spleen, liver). In this series, intracranial pathology was the most common cause of death in ECMO patients, related to gestational age, acidosis, hypoxia, and size, but probably unrelated to carotid ligation.

摘要

体外膜肺氧合(ECMO)是支持呼吸衰竭新生儿的重要手段。虽然对ECMO幸存者的短期和长期随访已有详尽研究,但对于非幸存者尚无系统性研究。19例有尸检结果的新生儿ECMO非幸存者被分为两组:第1组:12例以颅内病变为主要死因的患者(出血8例,脑软化2例,梗死2例);第2组:7例非颅内主要死因的患者。第1组患者在ECMO治疗前酸中毒程度明显更高、血压更低,年龄和出生体重更小。在第2组患者中,2例患有膈疝的患者死于原发性肺部疾病(弥漫性肺泡损伤、肺发育不全和坏死、支气管肺炎)。2例持续性胎儿循环(PFC)患者中的1例接受了大剂量妥拉唑啉治疗,死于致命性胃肠道出血以及心脏、脾脏、睾丸和肾上腺的缺血性坏死。另1例PFC患者有严重的肺间质纤维化。2例胎粪吸入患者和1例链球菌败血症患者有弥漫性肺损伤和多器官衰竭(肾髓质坏死以及肾上腺、脾脏、肝脏梗死)。在本系列研究中,颅内病变是ECMO患者最常见的死因,与胎龄、酸中毒、缺氧和体型有关,但可能与颈动脉结扎无关。

相似文献

1
A clinical-pathological study of nonsurvivors of newborn ECMO.新生儿体外膜肺氧合治疗非存活者的临床病理研究
J Pediatr Surg. 1993 Feb;28(2):135-7. doi: 10.1016/s0022-3468(05)80258-1.
2
Prognostic determinants in extracorporeal membrane oxygenation for respiratory failure in newborns.
Ann Thorac Surg. 1990 Nov;50(5):720-3. doi: 10.1016/0003-4975(90)90669-w.
3
UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation. UK Collaborative ECMO Trail Group.英国新生儿体外膜肺氧合协作随机试验。英国体外膜肺氧合协作试验组。
Lancet. 1996 Jul 13;348(9020):75-82.
4
Two years' follow-up of newborn infants after extracorporeal membrane oxygenation (ECMO).体外膜肺氧合(ECMO)治疗后新生儿的两年随访
Eur J Cardiothorac Surg. 2000 Sep;18(3):328-33. doi: 10.1016/s1010-7940(00)00514-5.
5
Survivors of extracorporeal membrane oxygenation at 1 year of age: the relationship of primary diagnosis with health and neurodevelopmental sequelae.1岁时体外膜肺氧合治疗的幸存者:初始诊断与健康及神经发育后遗症的关系。
Pediatrics. 1995 Nov;96(5 Pt 1):907-13.
6
20-year experience of prolonged extracorporeal membrane oxygenation in critically ill children with cardiac or pulmonary failure.20 年危重病儿童心肺衰竭体外膜肺氧合延长治疗经验。
Ann Thorac Surg. 2012 May;93(5):1584-90. doi: 10.1016/j.athoracsur.2012.01.008. Epub 2012 Mar 14.
7
Extracorporeal membrane oxygenation for newborn respiratory failure.新生儿呼吸衰竭的体外膜肺氧合治疗
Ann Thorac Surg. 1986 Nov;42(5):529-35. doi: 10.1016/s0003-4975(10)60575-9.
8
The collaborative UK ECMO (Extracorporeal Membrane Oxygenation) trial: follow-up to 1 year of age.英国体外膜肺氧合协作试验:1岁时的随访
Pediatrics. 1998 Apr;101(4):E1. doi: 10.1542/peds.101.4.e1.
9
Probability of survival after prolonged extracorporeal membrane oxygenation in pediatric patients with acute respiratory failure. Extracorporeal Life Support Organization.小儿急性呼吸衰竭患者长时间体外膜肺氧合后的生存概率。体外生命支持组织。
Crit Care Med. 1995 Jun;23(6):1132-9. doi: 10.1097/00003246-199506000-00021.
10
Frequency of chronic lung disease in infants with severe respiratory failure treated with high-frequency ventilation and/or extracorporeal membrane oxygenation.接受高频通气和/或体外膜肺氧合治疗的重症呼吸衰竭婴儿慢性肺病的发生率
Crit Care Med. 1992 Mar;20(3):372-7. doi: 10.1097/00003246-199203000-00014.

引用本文的文献

1
Histological changes in the hearts of non-survivors of the UK collaborative trial of neonatal ECMO (extra corporeal membrane oxygen).英国新生儿体外膜肺氧合协作试验中死亡患者心脏的组织学变化。
Arch Dis Child Fetal Neonatal Ed. 1999 Jul;81(1):F30-4. doi: 10.1136/fn.81.1.f30.
2
Pathological complications of non-survivors of newborn extracorporeal membrane oxygenation.新生儿体外膜肺氧合治疗死亡病例的病理并发症
Arch Dis Child Fetal Neonatal Ed. 1994 Sep;71(2):F88-92. doi: 10.1136/fn.71.2.f88.